Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 79

    Erythromycin Price Fixation: NPPA Sets aside notification

    Erythromycin Price Fixation: NPPA Sets aside notification

    Ruby Khatun Khatun19 Jan 2018 3:39 PM IST
    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
    Biocon collaborates with Sandoz for next-generation biosimilars

    Biocon collaborates with Sandoz for next-generation biosimilars

    Ruby Khatun Khatun19 Jan 2018 10:30 AM IST
    New Delhi: Bio-pharmaceuticals firm Biocon announced a global partnership with Sandoz, a Novartis division, to develop, manufacture and commercialize...
    Patanjali to set up five institutes in Nagaland

    Patanjali to set up five institutes in Nagaland

    Ruby Khatun Khatun18 Jan 2018 10:30 AM IST
    Kohima: Nagaland State Chief Minister T R Zeliang announced a slew of investments made by the Patanjali Group in the state, after laying foundation...
    NPPA fixes ceiling prices of 33 more drugs, check out details

    NPPA fixes ceiling prices of 33 more drugs, check out details

    Ruby Khatun Khatun17 Jan 2018 2:08 PM IST
    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
    Sun Pharma settles patent litigation with Ironwood, Allergan

    Sun Pharma settles patent litigation with Ironwood, Allergan

    Ruby Khatun Khatun17 Jan 2018 10:00 AM IST
    New Delhi: Drug major Sun Pharma said it has settled a patent litigation with Ironwood Pharmaceuticals Inc and Allergan plc in the US over a generic...
    FDC Ban: Drugs Technical Advisory Board to review efficacy, safety, justification of drugs

    FDC Ban: Drugs Technical Advisory Board to review efficacy, safety, justification of drugs

    Ruby Khatun Khatun16 Jan 2018 5:13 PM IST
    New Delhi: The Drugs Technical Advisory Board (DTAB) is expected to set up expert committees to review the safety, efficacy and therapeutic...
    Over 92 percent people do not trust healthcare system in India: Study

    Over 92 percent people do not trust healthcare system in India: Study

    Ruby Khatun Khatun16 Jan 2018 10:48 AM IST
    New Delhi: Over 92 percent people do not trust healthcare system in India, with the hospital being the most distrusted organization followed by Pharma...
    NITI Aayog asked to revamp process of drug selection for price control

    NITI Aayog asked to revamp process of drug selection for price control

    Ruby Khatun Khatun15 Jan 2018 4:19 PM IST
    New Delhi: The system of selections of drugs for Price Control may now undergo a sea change as the government has asked the NITI Aayog to revamp the...
    Fortis, RHT Health extend discussion time by 30 days

    Fortis, RHT Health extend discussion time by 30 days

    Ruby Khatun Khatun15 Jan 2018 10:00 AM IST
    New Delhi: Fortis Health Management and Singapore-listed RHT Health Trust have extended exclusivity period to finalize the proposed acquisition by 30...
    Aurobindo, Zydus Cadila, Torrent Pharma show interest to buy Sanofi 2 billion dollar European generics business

    Aurobindo, Zydus Cadila, Torrent Pharma show interest to buy Sanofi 2 billion dollar European generics business

    Ruby Khatun Khatun14 Jan 2018 11:51 AM IST
    MUMBAI: Aurobindo, Zydus Cadila, Torrent Pharma and Intas have shown their interest to buy the European generics business of pharma giant...
    Plan to reduce medicine prices faces industry pushback: Report

    Plan to reduce medicine prices faces industry pushback: Report

    Ruby Khatun Khatun14 Jan 2018 10:08 AM IST
    India’s proposal to curb drug prices by stripping generic medicines of their brand names has stalled after the plan faced pushback from the country’s...
    First: Health Ministry Panel wants JnJ to pay at least Rs 20 lakh to patients for faulty implants

    First: Health Ministry Panel wants JnJ to pay at least Rs 20 lakh to patients for faulty implants

    Ruby Khatun Khatun13 Jan 2018 4:07 PM IST
    New Delhi: Compensation has been recommended by a panel set up by the health ministry, in order to provide relief to patients who received faulty hip...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok